Alleviant ALLAY-HF Study

NCT ID: NCT05685303

Last Updated: 2025-10-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Clinical Phase

NA

Total Enrollment

500 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-01-10

Study Completion Date

2032-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Prospective, multicenter, randomized, sham-controlled, double blinded, adaptive study designed to evaluate the safety and efficacy of a percutaneously created interatrial shunt using the Alleviant ALV1 System in patients with HFpEF/HFmrEF.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Treatment

Subjects randomized to the treatment arm will undergo cardiac imaging, femoral vein access and receive the Alleviant ALV1 System device procedure.

Group Type EXPERIMENTAL

Alleviant ALV1 System

Intervention Type DEVICE

Creation of interatrial shunt

Control

Subjects randomized to the control arm will undergo cardiac imaging and sheath placement in femoral vein.

Group Type SHAM_COMPARATOR

Sham-Control

Intervention Type OTHER

Cardiac imaging

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Alleviant ALV1 System

Creation of interatrial shunt

Intervention Type DEVICE

Sham-Control

Cardiac imaging

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Symptomatic HFpEF/HFmrEF with LVEF greater than or equal to 40%
2. NYHA Class II, III or ambulatory IV
3. Exercise right heart catheterization\*

1. Elevated left atrial pressure during exercise right heart catheterization (greater than or equal to 25 mmHg)
2. Exercise PVR \< 1.8 WU
4. Ongoing stable GDMT

Exclusion Criteria

1. Advanced heart failure
2. Presence of a pacemaker
3. Evidence of right heart dysfunction
Minimum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Alleviant Medical, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

James Udelson, MD

Role: PRINCIPAL_INVESTIGATOR

Tufts Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Alabama

Birmingham, Alabama, United States

Site Status

Arizona Cardiovascular Research Center

Phoenix, Arizona, United States

Site Status

Pima Heart and Vascular

Tucson, Arizona, United States

Site Status

Memorial Care Long Beach Medical Center

Long Beach, California, United States

Site Status

UC Davis Medical Center

Sacramento, California, United States

Site Status

Scripps Clinical Research Services

San Diego, California, United States

Site Status

San Francisco VA

San Francisco, California, United States

Site Status

University of California San Francisco

San Francisco, California, United States

Site Status

Santa Barbara Cottage Hospital

Santa Barbara, California, United States

Site Status

Hartford Hospital

Hartford, Connecticut, United States

Site Status

The Cardiac and Vascular Institute (TCAVI)

Gainesville, Florida, United States

Site Status

HCA Florida Memorial Hospital

Jacksonville, Florida, United States

Site Status

NCH Research Institute

Naples, Florida, United States

Site Status

Advent Health Orlando

Orlando, Florida, United States

Site Status

Ascension Sacred Heart

Pensacola, Florida, United States

Site Status

Atlanta VA Health Care System

Decatur, Georgia, United States

Site Status

Advocate Illinois Masonic Medical Center

Chicago, Illinois, United States

Site Status

Midwest Cardiovascular Institute

Naperville, Illinois, United States

Site Status

Prairie Education and Research Cooperative

Springfield, Illinois, United States

Site Status

Indiana University

Indianapolis, Indiana, United States

Site Status

St. Elizabeth Healthcare

Edgewood, Kentucky, United States

Site Status

Cardiovascular Institute of the South

Houma, Louisiana, United States

Site Status

University Medical Center New Orleans

New Orleans, Louisiana, United States

Site Status

Johns Hopkins Medical Institution

Baltimore, Maryland, United States

Site Status

Brigham and Women's Hospital

Boston, Massachusetts, United States

Site Status

Boston Medical Center

Boston, Massachusetts, United States

Site Status

VA Ann Arbor

Ann Arbor, Michigan, United States

Site Status

Minneapolis Heart Institute Foundation

Minneapolis, Minnesota, United States

Site Status

Washington University - St Louis

St Louis, Missouri, United States

Site Status

VA NY Harbor Healthcare System

New York, New York, United States

Site Status

New York University

New York, New York, United States

Site Status

Lenox Hill Hospital

New York, New York, United States

Site Status

St. Francis Hospital

Roslyn, New York, United States

Site Status

Stony Brook Medicine

Stony Brook, New York, United States

Site Status

Mission Hospital

Asheville, North Carolina, United States

Site Status

Duke University Hospital

Durham, North Carolina, United States

Site Status

NC Heart and Vascular Research

Raleigh, North Carolina, United States

Site Status

Cleveland Clinic

Cleveland, Ohio, United States

Site Status

ProMedica Toledo Hospital

Toledo, Ohio, United States

Site Status

South Oklahoma Heart Research, LLC.

Oklahoma City, Oklahoma, United States

Site Status

Providence St. Vincent's Medical Center

Portland, Oregon, United States

Site Status

Pinnacle Health Cardiovascular Institute

Harrisburg, Pennsylvania, United States

Site Status

Prisma Health - Midlands

Columbia, South Carolina, United States

Site Status

Monument Health

Rapid City, South Dakota, United States

Site Status

Stern Cardiovascular Foundation

Germantown, Tennessee, United States

Site Status

Tennova Healthcare - Turkey Creek Medical Center

Knoxville, Tennessee, United States

Site Status

Hendrick Health

Abilene, Texas, United States

Site Status

Austin Heart

Austin, Texas, United States

Site Status

UT Southwestern

Dallas, Texas, United States

Site Status

Baylor Scott & White Research Institute

Plano, Texas, United States

Site Status

NextStage Clinical Research

Waco, Texas, United States

Site Status

University of Washington

Seattle, Washington, United States

Site Status

Advocate Aurora Health/Aurora Research Institute

Milwaukee, Wisconsin, United States

Site Status

Monash Health Victorian Heart Hospital

Clayton, Victoria, Australia

Site Status

Royal Adelaide Hospital

Adelaide, , Australia

Site Status

Medizinische Universität Graz

Graz, , Austria

Site Status

OLV Hospital

Aalst, , Belgium

Site Status

ZNA Middelheim

Antwerp, , Belgium

Site Status

AZ Sint Jan Brugge

Bruges, , Belgium

Site Status

Southlake Regional Hospital Centre

Newmarket, Ontario, Canada

Site Status

Centre hospitalier de l'Universite de Montreal (CHUM)

Montreal, Quebec, Canada

Site Status

Centre Integre Universitaire de Sainte et de Services Scoiiaux de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke (CIUSSS de l'Estrie - CHUS)

Montreal, Quebec, Canada

Site Status

Tbilisi Heart and Vascular

Tbilisi, , Georgia

Site Status

Heart and Vascular Center-Bad Bevensen

Bad Bevensen, , Germany

Site Status

Herz- und Gefasszentrum Bad Bevensen

Bad Bevensen, , Germany

Site Status

University of Gießen

Giessen, , Germany

Site Status

Marienkrankenhaus

Hamburg, , Germany

Site Status

Askelepios Klinik Altona

Hamburg, , Germany

Site Status

St. Vincentius Kliniken

Karlsruhe, , Germany

Site Status

Universitatsklinikum Schleswig-Holstein (UKSH)

Lübeck, , Germany

Site Status

Universitätsklinikum Kardiologie

Magdeburg, , Germany

Site Status

Universitatsmedizin Rostock

Rostock, , Germany

Site Status

European Interbalken Medical Center

Thessaloniki, , Greece

Site Status

Shaare Zedek Medical Center

Jerusalem, , Israel

Site Status

Tel Aviv Sourasky Medical Center

Tel Aviv, , Israel

Site Status

Shamir Medical Center

Zrifin, , Israel

Site Status

Humanitas Research Milan

Rozzano, MI, Italy

Site Status

Instituto Auxologico Italiano

Milan, , Italy

Site Status

ChristChurch Hospital

Christchurch, , New Zealand

Site Status

Dunedin Hospital

Dunedin, , New Zealand

Site Status

Poznan University of Medical Sciences

Poznan, , Poland

Site Status

4th Military Hospital

Wroclaw, , Poland

Site Status

Uniwesytecki Szpital Kliniczny

Wroclaw, , Poland

Site Status

Silesian Center for Heart Disease

Zabrze, , Poland

Site Status

Hospital de la Santa Creu i Sant Pau

Barcelona, , Spain

Site Status

Barcelona Hospital del Mar

Barcelona, , Spain

Site Status

Hospital Clinic de Barcelona

Barcelona, , Spain

Site Status

Hospital Universitario Puerta de Hierro

Madrid, , Spain

Site Status

Hospital Clínico Universitario de Salamanca

Salamanca, , Spain

Site Status

Valencia Hospital Clinico

Valencia, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Australia Austria Belgium Canada Georgia Germany Greece Israel Italy New Zealand Poland Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CIP-0003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The SMART-LV Pilot Study
NCT05630170 COMPLETED NA
Image Supported Lead Placement in CRT
NCT05053568 ACTIVE_NOT_RECRUITING NA
The IMPULSE Study: Pilot
NCT02044471 COMPLETED NA